1. Home
  2. MCHX vs ASRT Comparison

MCHX vs ASRT Comparison

Compare MCHX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.36

Market Cap

66.3M

ML Signal

HOLD

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

BUY

Current Price

$13.36

Market Cap

76.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MCHX
ASRT
Founded
2003
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
76.0M
IPO Year
2003
2004

Fundamental Metrics

Financial Performance
Metric
MCHX
ASRT
Price
$1.36
$13.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
10.6K
42.2K
Earning Date
03-25-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
52.17
N/A
EPS
N/A
N/A
Revenue
$90,291,000.00
$118,713,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.70
$16.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$0.51
52 Week High
$2.30
$13.90

Technical Indicators

Market Signals
Indicator
MCHX
ASRT
Relative Strength Index (RSI) 37.07 66.87
Support Level $1.35 $0.69
Resistance Level $1.76 N/A
Average True Range (ATR) 0.06 0.65
MACD 0.01 0.14
Stochastic Oscillator 0.00 78.95

Price Performance

Historical Comparison
MCHX
ASRT

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: